Loading...
•
Dec 31, 2019
ClearPoint Neuro Q4 2019 Earnings Report
Reported a 41% increase in fourth quarter revenue, marking the fifth consecutive quarter of revenue growth.
Key Takeaways
ClearPoint Neuro reported a 53% increase in revenue for the full year 2019, with fourth-quarter revenue growing by 41%. The company saw growth across all four segments of its business and secured over $25 million in financing from strategic partners.
Total revenues increased by 53% year-over-year for 2019.
Functional neurosurgery revenue increased by 29% for 2019, driven by a 20% increase in cases utilizing the ClearPoint Neuro Navigation System.
Biologics and drug delivery revenue increased by 116% for 2019, due to growth in clinical services and product sales.
Capital equipment sales and related service revenue increased for 2019, primarily due to an increase in sales of ClearPoint systems.
Revenue by Segment
Forward Guidance
The company expects to submit or introduce several new products in 2020 and believes new biologics and gene therapy partnerships will lead to exciting new applications.
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...